A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease
Status:
Completed
Trial end date:
2019-03-15
Target enrollment:
Participant gender:
Summary
A double-masked, randomized, multi-center, placebo-controlled, parallel-group study in adult
patients with Dry Eye Disease (DED). Patients will be randomly assigned to receive either
SJP-0035 0.001% or placebo